Calendario de promoción Sosei Group Corporation
Horario avanzado
gráfico sencillo
Acerca de la empresa Sosei Group Corporation
Sosei Group Corporation develops biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair to treat asthma; and ORAVI, an oropharyngeal candidiasis. más detallesIndustry | Biotechnology |
---|---|
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 0 |
Дивиденд ао | 1583.28 |
Сайт | https://soseiheptares.com |
Цена ао | 10.53 |
Cambio de precio por día: | 0% (6.1575) |
---|---|
Cambio de precio por semana.: | 0% (6.1575) |
Cambio de precio por mes: | -23.53% (8.052) |
Cambio de precio en 3 meses.: | -32.7% (9.15) |
Cambio de precio en seis meses: | -34.7% (9.43) |
Cambio de precio por año: | -38.43% (10) |
Cambio de precio en 3 años.: | -63.61% (16.92) |
Cambio de precio en 5 años.: | -23.32% (8.03) |
Cambio de precio en 10 años.: | 0% (6.1575) |
Cambio de precio desde principios de año.: | -23.53% (8.052) |
|
Subestimación
|
Eficiencia
|
|||||||||||||||||||||||||||||||||||||
Dividendos
|
Deber
|
Impulso de crecimiento
|
Instituciones | Volumen | Compartir, % |
---|---|---|
Smallcap World Fund | 1841200 | 2.06 |
Vanguard International Stock Index-Total Intl Stock Indx | 997900 | 1.12 |
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund | 604000 | 0.68 |
iShares Core MSCI EAFE ETF | 441300 | 0.49 |
iShares MSCI EAFE Small Cap ETF | 284100 | 0.32 |
Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index | 278200 | 0.31 |
Schwab Strategic Tr-Schwab International Small Cap Equity ETF | 149344 | 0.17 |
iShares Core MSCI Total International Stock ETF | 129600 | 0.14 |
Vanguard International Stock Index-Pacific Stock Index | 89400 | 0.1 |
iShares Core MSCI International Developed Markets ETF | 62100 | 0.07 |
Supervisor | Título profesional | Pago | año de nacimiento |
---|---|---|---|
Mr. Christopher Cargill | Representative Executive Officer, President, CEO & Director | 1.25M | 1984 (41 año) |
Mr. Hironoshin Nomura | Executive Officer, Executive VP & CFO | N/A | 1983 (42 año) |
Mr. Kieran Johnson F.C.A. | Executive Officer, Executive VP & Chief Accounting Officer | N/A | 1969 (56 años) |
Mr. Toshihiro Maeda | Executive VP & COO | N/A | 1979 (46 años) |
Mr. Kazuhiko Yoshizumi | Executive Officer, Executive VP & Chief Compliance Officer | N/A | 1954 (71 año) |
Shinichiro Nishishita | VP of Investor Relations & Head of Regulatory Disclosures | N/A | |
Stacey Southall | Associate Director & Head of Biophysics | N/A | |
Ms. Candelle Chong | Executive Officer, Executive VP, CEO Office & Chief of Staff | N/A | 1989 (36 años) |
Dr. Satoshi Tanaka | Exe. Off., Executive VP and President of Idorsia Pharmaceuticals Japan & Nxera Pharma Japan | N/A | 1957 (68 años) |
Dr. Shinichi Tamura | Founder & Chairman of the Board | 1949 (76 años) |
DIRECCIÓN: Japan, Tokyo -, PMO Hanzomon - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://soseiheptares.com
Sitio web: https://soseiheptares.com